Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Breast cancer

The importance of overdiagnosis in breast-cancer screening

Nature Reviews Clinical Oncology volume 13, pages 5–6 (2016)Cite this article

Subjects

The results of three recent studies demand that more attention be placed on defining the most-appropriate approach to population-based breast-cancer screening, in particular regarding the potential harms of increasing overdiagnosis. Two of these studies report that more-sensitive detection of breast neoplasms is possible by 3D tomography and by MRI, but the third paper raises the question of whether this increased sensitivity is desirable.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Lång, K. et al. Performance of one-view breast tomosynthesis as a stand-alone breast cancer screening modality: results from the Malmö Breast Tomosynthesis Screening Trial, a population-based study. Eur. Radiol. http://dx.doi.org/10.1007/s00330-015-3803-3.

  2. Harding, C. et al. Breast cancer screening, incidence, and mortality across US counties. JAMA Intern. Med. 175, 1483–1489 (2015).

    Article  Google Scholar 

  3. Bleyer, A. & Welch, H. G. Effect of three decades of screening mammography on breast-cancer incidence. N. Engl. J. Med. 367, 1998–2005 (2012).

    Article  CAS  Google Scholar 

  4. Narod, S. A., Iqbal, J. & Miller, A. B. Why have breast cancer mortality rates declined? J. Cancer Policy http://dx.doi.org/10.1016/j.jcpo.2015.03.002.

  5. Mohammed, H. et al. Progesterone receptor modulates ERα action in breast cancer. Nature 523, 313–317 (2015).

    Article  CAS  Google Scholar 

  6. Narod, S. A., Valentini, A., Nofech-Mozes, S., Sun, P. & Hanna, W. Tumour characteristics among women with very low-risk breast cancer. Breast Cancer Res. Treat. 134, 1241–1246 (2012).

    Article  CAS  Google Scholar 

  7. Simos, D. et al. Imaging for distant metastases in women with early-stage breast cancer: a population-based cohort study. CMAJ 187, E387–E397 (2015).

    Article  Google Scholar 

  8. Sopik, V. & Narod, S. A. Overdiagnosis in breast cancer chemoprevention trials. Curr. Oncol. 22, e6–e10 (2015).

    Article  CAS  Google Scholar 

  9. Narod, S. A. Tamoxifen chemoprevention — end of the road? JAMA Oncol. http://dx.doi.org/10.1001/jamaoncol.2015.2247.

  10. Narod, S. A., Giannakeas, V., Iqbal, J., Sopik, V. & Sun, P. Breast cancer mortality after a diagnosis of ductal carcinoma in situ (DCIS). JAMA Oncol. 1, 888–896 (2015).

    Article  Google Scholar 

  11. Narod, S. A. Disappearing breast cancers. Curr. Oncol. 19, 59–60 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Saadatmand, S., Bretveld, R., Siesling, S. & Tilanus-Linthorst, M. M. Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173,797 patients. BMJ 351, h4901 (2015).

    Article  Google Scholar 

  13. Miller, A. B. et al. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ 348, g366 (2014).

    Article  Google Scholar 

  14. Kuhl, C. K. et al. Breast MRI screening of women at average risk of breast cancer: an observational cohort study [abstract]. J. Clin. Oncol. 33 (Suppl. 28S), a1 (2015).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Women's College Research Institute, 76 Grenville Street, Suite 6418, Toronto, M5S 1B2, ON, Canada

    Steven Narod

Authors
  1. Steven Narod
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Steven Narod.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Narod, S. The importance of overdiagnosis in breast-cancer screening. Nat Rev Clin Oncol 13, 5–6 (2016). https://doi.org/10.1038/nrclinonc.2015.203

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrclinonc.2015.203

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer